Skip to main content
. 2021 Jan 5;4(1):4–17. doi: 10.1136/bmjnph-2020-000183

Figure 5.

Figure 5

Graphical summary on the effects of beego on thrombosis and haemostasis. In a beego programme, the potentially transit mild thrombosis risk in fasting period is reversible by refeeding; Beego maintains haemostasis capacity and limits platelet generation and activation to reduce thrombosis risk.